Global Medical Adhesives Market By Technology (Water Based, Solvent Based, Hot Melt, Others), By Resin Type (Natural v/s Synthetic & Semi-Synthetic), By Natural Resin Type (Collagen, Fibrin, Others), By Synthetic & Semi-Synthetic Resin Type (Cyanoacrylate, Epoxy, Acrylic, Polyurethane, Others), By Application (Dental, Surgery, Medical Devices, Others), By Region, Competition Forecast and Opportunities, 2027
New York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Medical Adhesives Market - Competition Forecast and Opportunities, 2027" - https://www.reportlinker.com/p06325876/?utm_source=GNW The global medical adhesive market is anticipated to observe impressive growth during the forecast period, 2023-2027.The major factors which include increase in consumption of bio-adhesive medical instruments, implants, wound healing and internal medical treatment. Medical adhesives are built to adhere the biological tissues and are more efficient to wounds.The other factors such as disposable medical products, and its cost-effectiveness are expected to boost the medical adhesive market, globally. Additionally, the growing interest of government on public health has also fueled the need for more advanced and specific equipment in healthcare settings. Surging focus on the infection prevention and escalating volume of outpatient, surgical and hospitals are expected to bolster the demand for single use medical products, which will ensure the expansion of the medical adhesive market in the upcoming years. Increasing Geriatric Population and Sedentary Lifestyle Choices Key reasons for the growth of the global medical adhesive include surge in geriatric population and sedentary lifestyle choices resulting in increased incidences of cardiovascular disease, which in turn elevating the demand for medical adhesives through 2027. Single Use Medical Products Single use or disposable medical products are preferred over traditional medical instruments as they eliminate the human interaction or the cross-contamination, low investments, more hygiene, assured sterility, portable and less regulatory concerns.It majorly depends upon the syringe-molded plastic, grouped by bonding, gluing, welding (Ultrasonic or radiofrequency). Additionally, the expansion of health institutes and emphasis of government on public health has skyrocketed the demand for the disposable medical products. Technological Advancements Over the past few years, immense growth and developments has been witnessed in medical adhesive market.Design engineers and medical diagnostics are continuously working in order to modify and create advance technology to bolster the growth of the medical adhesive market. For instance, in 2020, 3M launched Hi-Tack Silicon Adhesive Tapes that have longer worn duration, heavier device support and are more secured. Market Segmentation The global medical adhesive market is segmented into technology, resin type, natural Resin Type, Synthetic & Semi-Synthetic Resin Type, By Application, By Company.Based on technology, the market is divided into Water Based, Solvent Based, Hot Melt, and Others. Based on Resin Type, the market is divided into Natural v/s Synthetic & Semi-Synthetic.Based on Natural Resin Type, the market is divided into Collagen, Fibrin, and Others. Based on, the market is divided into Cyanoacrylate, Epoxy, Acrylic, Polyurethane, and Others.Based on Application, the market is divided into Dental, Surgery, Medical Devices and Others. Based on Company. In terms of country, the United States is expected to be a lucrative market in the forecast period as the government is taking significant steps to develop new medical technologies and products in the country. Market Players Johnson & Johnson,3M Company, Henkel AG & CO KGAA, Baxter International, Inc., B. Braun Melsungen AG, H.B. Fuller Company, Ashland, Inc, Cohera Medical Inc, Arkema Group, Dow Chemical Company are some of the leading companies operating in the market. Report Scope: In this report, global medical adhesive market has been segmented into following categories, in addition to the industry trends which have also been detailed below: • Medical Adhesives Market, By Technology: o Water Based o Solvent Based o Hot Melt o Others • Medical Adhesives Market, By Resin Type: o Natural o Synthetic & Semi-Synthetic • Medical Adhesives Market, By Natural Resin Type: o Collagen o Fibrin o Others • Medical Adhesives Market, By Synthetic & Semi-Synthetic Resin Type: o Cyanoacrylate o Epoxy o Acrylic o Polyurethane o Others • Medical Adhesives Market, By Application: o Dental o Surgery o Medical Devices o Others • Medical Adhesives Market, By Region: o North America United States Canada Mexico o Asia-Pacific China India Japan Australia South Korea o Europe & CIS Germany France United Kingdom Spain Italy o South America Brazil Argentina Colombia o Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in Medical Adhesives Market Available Customizations: With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report: Company Information • Detailed analysis and profiling of additional market players (up to five). Read the full report: https://www.reportlinker.com/p06325876/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Investors are facing a storm of headwinds right now – a genuine bear market, stubbornly high inflation, rising interest rates, and increased fears of a recession in the near-term. However, Mary Callahan Erdoes, CEO of JPMorgan's Asset & Wealth Management division, advises investors to stay invested. "It's actually the easiest time in the world to find alpha — there is alpha everywhere... It's everywhere, because we are in such a state of change... While all the world is focused on all the black
The U.S. emergency oil reserves haven’t been this low in four decades.
Costco offers a very simple proposition to its members. Basically, Costco offers no frills -- its stores aren't just called warehouses, they actually are warehouses -- and items are basically just stacked on pallets. Costco also puts relentless pressure on its vendors to squeeze out every penny of cost from each item.
Gas prices are rising again, and this might be just the beginning.
The chip industry is in the early stages of a cyclical downturn right now, and Micron itself announced a big hit to its revenue and profits is upcoming. New York state, where Micron plans on spending up to $100 billion over the next two decades on a new megafab. It's huge news for Micron, New York, and the whole semiconductor industry, which is still grappling with fallout from the pandemic and a shaky supply chain that is highly reliant on overseas fabs.
Rivian Automotive is recalling nearly all of its vehicles to address a potential problem that could cause customers to lose steering control, the company said Friday. In rare cases, the problem could lead to a loss of steering control, the company said. The recall campaign covers about 13,000 vehicles built in the 2021 and 2022 calendar years, and there are no known injuries related to this defect, a company spokeswoman said.
Investing in Warren Buffett's biggest holdings can be a winning tactic, but don't overlook the companies that occupy smaller positions in Berkshire Hathaway's portfolio.
The cuts are intended to reduce costs, streamline operations and increase profitability for BioMarin, frequently tapped as a likely takeover target.
Wonder Pill quietly contained a drug used to treat erectile dysfunction, which could be deadly for some unknowing consumers, the FDA said.
Cannabis stocks dropped Friday after President Joe Biden on Thursday announced pardons for thousands of people convicted of marijuana possession under federal law. The president called on governors to take similar action for state offenses. Biden also said his administration will review whether cannabis should remain in its current federal category along with heroin and LSD — a move widely...
President Biden will pardon everyone who has been convicted of simple possession of marijuana under federal law, the White House announced Thursday. “There are thousands of people who have prior federal convictions for marijuana possession, who may be denied employment, housing, or educational opportunities as a result. My action will help relieve the collateral consequences…
(Bloomberg) -- Commodities have opened the fourth quarter in some style, with prices posting the biggest weekly gain since March after OPEC+ agreed to chop oil supply. The coming week will bring a host of signals on the outlook over the rest of the year and into 2023 before earnings season hits full flood. Most Read from BloombergBiden Says Putin Threats Real, Could Spark Nuclear ‘Armageddon’Biden Should Hit Saudi Arabia Where It Really HurtsNATO Once Feared a Putin Victory. Now It Worries Over
The companies that make up the S&P 500 would already be in a so-called earnings recession this year if it weren’t for higher oil prices.
The bull-and-bear debate around the prospects for copper and copper mining stocks, like Freeport-McMoRan (NYSE: FCX), continues to rage on. On the other hand, the bulls argue that both the demand and supply are favorable for the copper industry over the long term.
MOSCOW/HOUSTON (Reuters) -Russian President Vladimir Putin signed a decree on Friday that establishes a new operator for the Exxon Mobil Corp-led Sakhalin-1 oil and gas project in Russia's Far East. Putin's move affecting Exxon's largest investment in Russia mimics a strategy he used to seize control of other energy properties in the country. Exxon holds a 30% operator stake in Sakhalin-1, with Russian company Rosneft, India's ONGC Videsh and Japan's SODECO as partners.
These are the utilities stocks with the best value, fastest growth, and most momentum for October 2022.
Most people might not want to glance too often at their stock portfolio in 2022, but not everyone has had a rough year. Making good use of the UK market unrest, Crispin Odey's hedge fund has had a great one. In fact, with returns of a hefty 193% year-to-date, it has been a record year for the fund. How did the hedge fund tycoon do it? To a large extent, by going short against UK bonds and the British pound, a wise moving considering the pound plummeted even further in September after new Prime M
Canadian energy giant Enbridge has added a trio of big projects, which will help drive growth over the next five years.
The suspect allegedly fought with police while they tried to arrest him
The recent setback faced by KalVista (KALV) for terminating the phase II KOMPLETE study evaluating KVD824 for prophylactic treatment of hereditary angioedema hurts the stock.